Start Date
December 31, 2003
Study Completion Date
August 31, 2005
ILX651
US Oncology / Ocala Oncology, Ocala
Sarah Cannon Cancer Center, Nashville
US Oncology / Central Indiana Cancer Centers, Indianapolis
Hematology and Oncology Specialists, New Orleans
US Oncology / Texas Cancer Center, Dallas
US Oncology / Tyler Cancer Center, Tyler
Joe Arrington Cancer Center, Lubbock
Anshutz Cancer Pavillion, Aurora
US Oncology/ Arizona Clinical Research Center, Tucson
Cancer Institute Medical Group, Santa Monica
Genzyme, a Sanofi Company
INDUSTRY